ONEtoONE Corporate Finance’s Post

New Investor member: GBL (Groupe Bruxelles Lambert) is an established investment holding company, with seventy years of stock exchange listing and a net asset value of approximately €16 billion. As a leading and active investor in Europe, GBL focuses on long-term value creation with the support of a stable family shareholder base. Investing up to €2bn equity per platform, GBL’s investment teams target market leading companies with clear and sustainable business models, strong management teams and balanced leverage. GBL’s portfolio evolution toward more private assets has prioritized flagship investments in the healthcare sector. These include Affidea (pan-European provider of diagnostic imaging, outpatient and cancer care services) and Sanoptis (a European leader in ophthalmology services). Michal Chalaczkiewicz, Jimmy Piron, Rein Dirkx, Martin Doyen, Sarah Ward, Henry Elphick, Nick Herbert, Alan MacKay #privateequity #healthcare #investing #europe #diagnostics #ophthalmology

MedTech is recovering strongly as the market discounts the muted impact of GLP-1 drugs across the sector. In the face of indifferent performance from broader equities, the Cordis Global Medical Technology Fund is proving a worthy diversification tool.

🌟 Exciting news! After 15 months working with ILC Therapeutics as their fractional CFO, I’m thrilled to share that our recent fundraising round has been a success, and the cherry on top, my journey with the company continues 🚀. This round is a major milestone, helping us advance our two lead assets Alfacyte™ & Dermacyte™ towards clinic and hit key value inflection points for the business. 🎯 For those not in biotech, the closing of a fundraising round isn’t the time to slow down—it’s time to accelerate! 💥 and that's exactly what we are doing! I do have a sliver of capacity left (1-4 days/month) for fractional CFO work. If you or someone you know needs support, drop me a message! 📩 #FractionalCFO #FundraisingSuccess #Biotech #ClinicalTrials #Startups #CFO #BusinessGrowth #BiotechStartups #Leadership #Finance #Fundraising

Teleradiology Market is Booming! In 2024, Australia and New Zealand's I-med Radiology acquired StatRad, which is one of the largest teleradiology service providers in the US. This acquisition will help I-Med to enter the US teleradiology market. Arizton’s latest report is here with a comprehensive look at the latest trends and drivers shaping the market. Dive into the data on mergers and acquisitions, explore groundbreaking innovations and get the scoop of your competitors and their offerings.  Explore! https://lnkd.in/gEhgiGGu Key Players: Philips | Radiology Partners | Teleradiology Solutions | Everlight Radiology | 4ways | Cloudex Radiology | Cerner Corporation | FUJIFILM Corporation | ONRAD | RamSoft | Telediagnosis | Telerad Tech #teleradiologymarket #healthandwellness #Ariztonresearchreveals #marketresearch #marketinsights #researchreports

All eyes have been on Johnson & Johnson lately, as the company has aggressively expanded its footprint in the cardiovascular devices market with multiple high-value acquisitions over the past 24 months. These strategic moves have sparked a surge of investor and strategic interest in companies building in similar spaces. Our Market Intelligence team is diving deep into the implications of these acquisitions and other M&A activity in the space. Join us for our Cardiovascular Market Dive Webinar, where we’ll break down the latest data and provide actionable insights. Key topics we’ll cover include: • Global, regional, and country-level data and insights on cardiovascular procedure volumes • LSI’s findings on the latest trends and companies in the cardiovascular devices market • Select market analysis and projections, including global interventional cardiology devices, and more. Want to learn more? Register for the webinar on Wednesday, October 23rd using the link here: https://lu.ma/symjxuh1 See you there.

MedTech Mergers & Acquisitions are expected to see a big uptick in 2024 and 2025. Are Johnson & Johnson potentially looking to add to their big-ticket acquisitions in the #Cardiovascular space? This comes off the back of their $16B Abiomed aquisition in late 2022, potentially bolstering their presence in this high value market segment. I'm sure there's lots more exciting changes coming in the coming couple of years. Watch this space. https://lnkd.in/exniAkyz

According to The Business Times, global investment firm KKR & Co has emerged as the largest shareholder of one of Vietnam’s biggest eye hospital chains, Medical Saigon Group (MSG), according to an MSG internal memo seen by Reuters on Friday (Jan 19). Read the article for more details! Connect with us to get updated with the latest property news in Vietnam! #vietnamproperty #news #realestate

Merit Medical Systems, Inc. has announced its latest strategic move by acquiring Cook Medical’s lead management device portfolio for $210 million. This significant acquisition underscores Merit’s commitment to expanding its offerings and enhancing its support for cardiac intervention patients. The deal is expected to close in Q4 2024, with Merit Medical leveraging cash reserves and long-term credit for the purchase. CEO Fred P. Lampropoulos highlighted that this acquisition aligns with Merit’s growth strategy and will enable the company to offer a more comprehensive range of solutions from diagnosis to post-procedure care. Cook Medical’s lead management portfolio, which has generated $37 million in revenue in 2023, is a valuable addition. The portfolio has a strong presence in the U.S. and EMEA regions. The transaction is pending antitrust approval but includes a transition agreement with Cook Medical for continued support over the next two years. In addition to this acquisition, Merit Medical recently acquired the rights to the EsophyX Z+ device from EndoGastric Solutions for $105 million. #MedTech #HealthcareInnovation #Acquisition #MeritMedical #InterventionalRadiology #CardiacCare

Johnson & Johnson Concludes Acquisition Of Shockwave Medical Johnson & Johnson has announced it has completed its acquisition of Shockwave Medical. Shockwave is now part of Johnson & Johnson and will operate as a business unit within Johnson & Johnson MedTech. Shockwave is ultimately expected to become Johnson & Johnson MedTech’s thirteenth priority platform, as defined by annual sales of at least $1 billion. The transaction is expected to accelerate revenue growth for both Johnson & Johnson and Johnson & Johnson MedTech. Johnson & Johnson expects the transaction to be accretive to operating margin, but considering the impact of financing costs, is expected to dilute adjusted earnings per share by approximately $0.10 in 2024 and approximately $0.17 in 2025. In connection with the completion of the transaction, Shockwave’s common stock ceased trading on NASDAQ. Joaquin Duato Tim Schmid #johnsonandjohnson #johnsonandjohnsonnews #acquisition #shockwavemedical

🚀 **Lessons from Argentina's Copa America Victory: Insights for Clinical Pathology Labs** 🏆 Argentina’s Copa America success offers key lessons for managing clinical pathology laboratories. Here’s how their strategies can be applied: 1. **Unified Vision and Goals** 🎯 - Like Argentina’s clear objectives, set and communicate a unified mission in your lab. This alignment boosts efficiency and performance. 2. **Effective Leadership** 👥 - Strong leadership was crucial for Argentina. Similarly, inspiring and supporting lab staff fosters a motivated and productive team. 3. **Adaptability and Innovation** 🧠 - Argentina’s tactical adaptability mirrors the need for labs to embrace new technologies and methodologies to stay competitive. 4. **Teamwork and Collaboration** 🤝 - Team synergy was key for Argentina. Encourage collaboration in your lab to enhance problem-solving and efficiency. 5. **Preparation and Training** 📚 - Just as Argentina’s success came from rigorous practice, regular training ensures lab staff are prepared for complex cases. 6. **Resilience and Perseverance** 💪 - Argentina’s resilience in pressure situations highlights the importance of a positive attitude and resilience in overcoming lab challenges. 7. **Celebrate and Learn** 🏅 - Recognize achievements and learn from mistakes, as Argentina did. This approach promotes continuous improvement and boosts morale. Applying these principles can lead to a more effective, innovative, and successful clinical pathology lab. Let’s draw inspiration from Argentina’s victory to elevate our practices! ⚽🔬 #Leadership #Teamwork #Innovation #HealthcareManagement #ClinicalPathology #SuccessStrategies #CopaAmerica #ProfessionalDevelopment